Factors predicting severe radiation pneumonitis in patients receiving definitive chemoradiation for lung cancer. (Q52075813)

21 April 2018

title

Factors predicting severe radiation pneumonitis in patients receiving definitive chemoradiation for lung cancer. (English)

1 reference

21 April 2018

0 references

0 references

Robnett TJ

1

1 reference

21 April 2018

Machtay M

2

1 reference

21 April 2018

Vines EF

3

1 reference

21 April 2018

McKenna MG

4

1 reference

21 April 2018

Algazy KM

5

1 reference

21 April 2018

McKenna WG

6

1 reference

21 April 2018

language of work or name

English

0 references

publication date

1 August 2000

1 reference

21 April 2018

International Journal of Radiation Oncology Biology Physics

published in

1 reference

21 April 2018

volume

48

1 reference

21 April 2018

issue

1

1 reference

21 April 2018

page(s)

89-94

1 reference

21 April 2018

The Evolution of Radiation Therapy Oncology Group (RTOG) protocols for nonsmall cell lung cancer

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900648-9

7 January 2021

Characteristics of long-term survivors after treatment for inoperable carcinoma of the lung

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900648-9

7 January 2021

Clinical practice guidelines for the treatment of unresectable non-small-cell lung cancer. Adopted on May 16, 1997 by the American Society of Clinical Oncology

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900648-9

7 January 2021

Phase II study of 3-hour infusion of paclitaxel in patients with previously untreated stage III and IV non-small cell lung cancer. West Japan Lung Cancer Group

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900648-9

7 January 2021

The influence of field size and other treatment factors on pulmonary toxicity following hyperfractionated irradiation for inoperable non-small cell lung cancer (NSCLC)--analysis of a Radiation Therapy Oncology Group (RTOG) protocol

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900648-9

7 January 2021

CHRONIC BRONCHITIS AND RADIOTHERAPY OF THE LUNG

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900648-9

7 January 2021

SEQUELAE OF RADICAL RADIOTHERAPY OF CARCINOMA OF THE LUNG

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900648-9

7 January 2021

A prospective randomized study of various irradiation doses and fractionation schedules in the treatment of inoperable non-oat-cell carcinoma of the lung. Preliminary report by the Radiation Therapy Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900648-9

7 January 2021

The effect of dose rate and adriamycin on the tolerance of thoracic radiation in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900648-9

7 January 2021

Effect of cancer chemotherapeutic drugs on radiation-induced lung damage in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900648-9

7 January 2021

Response, toxicity, failure patterns, and survival in five Radiation Therapy Oncology Group (RTOG) trials of sequential and/or concurrent chemotherapy and radiotherapy for locally advanced non-small-cell carcinoma of the lung

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900648-9

7 January 2021

Hyperfractionated radiation therapy with or without concurrent low-dose daily carboplatin/etoposide for stage III non-small-cell lung cancer: a randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900648-9

7 January 2021

Effects of Concomitant Cisplatin and Radiotherapy on Inoperable Non-Small-Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900648-9

7 January 2021

A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900648-9

7 January 2021

Radiation pneumonitis: a possible lymphocyte-mediated hypersensitivity reaction.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900648-9

7 January 2021

Radiation and the lung: a reevaluation of the mechanisms mediating pulmonary injury

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900648-9

7 January 2021

Radiation pneumonitis following combined modality therapy for lung cancer: analysis of prognostic factors

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900648-9

7 January 2021

Strategy for dose escalation using 3-dimensional conformal radiation therapy for lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900648-9

7 January 2021

Radiation pneumonitis as a function of mean lung dose: an analysis of pooled data of 540 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900648-9

7 January 2021

Dose-volume histogram and 3-D treatment planning evaluation of patients with pneumonitis

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900648-9

7 January 2021

Dose escalation for non-small cell lung cancer using conformal radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900648-9

7 January 2021

10.1016/S0360-3016(00)00648-9

Identifiers

DOI

1 reference

21 April 2018

1 reference

21 April 2018